Navigation Links
Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
Date:3/19/2008

Clinical Data Presented at SIR Meeting Indicates New Catheter-based Treatment Could Soon Become the Standard of Care for Treating Acute DVT

WASHINGTON, March 19 /PRNewswire/ -- Registry clinical data presented this week at the Society of Interventional Radiology's 33rd Annual Scientific Meeting shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes.

This technique restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques. It provides an important adjunct to the standard therapy of anti-coagulation alone, which is intended to prevent future clots but does not break up the existing clot.

Gerard O'Sullivan, MD, Interventional Radiologist from University Hospital in Galway, Ireland, reported the latest outcomes from the manufacturer's registry of clinical results of the Trellis catheter at over 360 hospitals in the U.S. and internationally.

In a total of 827 limbs treated in 771 patients, Grade II and III lysis with restoration of patency in patients with acute clot was achieved in 97% of cases. The vast majority of cases (> 80%) were completed in less than two hours in the single-setting of the interventional suite, and the usage of the Trellis catheter itself was typically around 20 minutes. Although required with CDT procedures, no follow-up monitoring in a costly critical care unit was typically needed with the Trellis catheter treatment.

There were no reported bleeding complications from the Trellis procedure in acute follow up and compared to CDT the dosage of thrombolytic drugs such as t-PA are appreciably reduced with use of the Trellis device.

"The single biggest change in treating DVT patients with the Trellis catheter is our ability to get the clot out and have the patients able to walk away immediately after the procedure," said Dr
'/>"/>

SOURCE Bacchus Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
2. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
3. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
4. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
5. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
6. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
7. New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
8. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
9. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009).... 27 ACUO TECHNOLOGIES, developers...ware, data migration tools and services, is please...ademark Office has approved a patent application f...r Network." Acuo Technologies is pleased to add th...perty. In general, the granted patent application ...
(Date:11/26/2009)...th Africa, Nov. 26 The 2009 Frost ...ard in the Generic Pharmaceutical Market is presen...ogo: http://www.newscom.com/cgi-bin/prnh/20081117... the following criteria were used to benchmark Cip...rowth strategy and implementation, degree of innov...
(Date:11/25/2009)...ov. 25 American Scientif...y") is pleased to announce that they have opened a...ce in Shanghai, China. ,, ASR has been able to ...ateway for the development and production of curre...ren and adults to be distributed and sold globally...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 51201 1MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 51201 2MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 51201 3Life Spine 28R 29 Announces FDA Clearance of FS3 28TM 29 Minimally Invasive Spinal System 51196 1
...s to be Presented at the North American Menopause ... Meeting, EMERYVILLE, Calif., Sept. 25 Bionovo, ...a presentation on their new drug,candidate, VG101,... Annual,Meeting of the North American Menopause So...r. Mary Tagliaferri, president and chief medical,o...
...ance of cleaning floor drains often underestimated...ation protocols, ATLANTA, Sept. 24 Recent media ...rs concerned about food safety. As a result of the...tailers, and food service,companies are reviewing ...ls in order to reduce the risk of food contaminati...
Other Medicine Technology:Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 3Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains 2Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains 3
(Date:11/29/2009)...get blamed for something leads to more self-defens...DAY, Nov. 29 (HealthDay News) -- The blame game is...the target is innocent. , Researchers found tha... problem, even if it,s an unfair accusation, they,...oo. , "When we see others protecting their ego...
(Date:11/28/2009)...GO, Nov. 28 Welcome to syngo&#...r the clinical routine from Siemens Healthcare. ...ons System (PACS) from Siemens where 2D, 3D, and... .plaza is poised to change the way multimodality ...nnovation at the 95th Scientific Assembly and An...
(Date:11/27/2009)...D, Mass., Nov. 27 GSI Gr...pplier of precision technology products and semico...eting of the Company,s shareholders has been sched...ation of the meeting will be announced in due cour... a requisition notice from Stephen Bershad, a hold...
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)...ing unprecedented medical, economic burdens, study... News) -- The number of people with diabetes in th...t 25 years, a new study predicts. , That would ...le with the disease, up from 23.7 million today. ,... with diabetes will triple, the study also warns, ...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... very optimistic about Warfarin, an anti-clotting ...in patients suffering an abnormal heart rhythm, th...scores over the present treatment of Plavix plus a...,' Oral anticoagulants such as warfarin remain the...
...Pentagon placed new restrictions on a doctors’ ro... against any policy //that gives medical professi...ters’ to use harsher tactics than they would in t...ghts groups and medical ethicists. They charge tha...
...twins Amal and Amrutha, who became orphaned after ...ll be formally adopted by the Kerala Government at...being organised by Cheruvathur Grama Panchayat to ...a recent Cabinet meeting mooted the idea of adopti...
... popular excuse "not tonight, I have a headache," ...oid sexual activity and says that sexual desire an...mical. // In fact, migraine sufferers report...d colleagues. 'Migraine patients in general m...
...as long been associated with mesothelioma and lung...gnancies as well //. The Indian Institute of...addition IOM also concluded that there was ‘sugges...fficient evidence to relate asbestos to esophageal...
...nd Healthcare products Regulatory Agency (MHRA) wa...ulty readings. The diabetic patients are cautioned...e found to giving readings which were far too high...s of insulin resulting in hypoglycaemic coma. ...
Other Medicine News:Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:Laryngeal Cancer Added to Asbestos’ Crime Lis 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: